Parkinson's Disease: Research
(asked on 2nd May 2024) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what funding the (a) National Institute for Health and Care Research and (b) UK Research Institute has provided for Parkinson's research in each of the last five years.
The Government’s responsibility for delivering Parkinson’s disease research is shared between the Department of Health and Social Care, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology (DSIT), with research delivered via UK Research and Innovation (UKRI). Between the financial years 2019/20 and 2023/24, the Department of Health and Social Care, via the NIHR, funded Parkinson’s research projects to a total value of £12.9 million of programme spend.
As well as funding research itself, the NIHR invests significantly in research expertise and capacity, specialist facilities, support services, and collaborations, to support and deliver research in England. Collectively this forms the NIHR’s infrastructure. The NIHR’s infrastructure enables the country’s leading experts to develop and deliver high-quality translational, clinical, and applied research into Parkinson’s disease. For example, in the financial year 2022/23, the NIHR Clinical Research Network supported 114 studies related to Parkinson’s disease. UKRI spent over £66 million on research into Parkinson’s disease between the financial years 2019/20 and 2023/24. The following table shows the breakdown of spend on Parkinson's research for the NIHR and UKRI, each year from 2019/20 to 2023/24:
| NIHR programmes | UKRI | Total |
2019/20 | £2,470,000 | £18,200,000 | £20,680,000 |
2020/21 | £2,180,000 | £11,970,000 | £14,160,000 |
2021/22 | £2,620,000 | £13,010,000 | £15,640,000 |
2022/23 | £2,570,000 | £11,890,000 | £14,470,000 |
2023/24 | £3,030,000 | £11,060,000 | £14,090,000 |
Total | £12,900,000 | £66,150,000 | £79,060,000 |